Back to Treatments

Treatment

Retroperitoneal Lymph Node Dissection (RPLND)

1
Conditions
7
Trials
50K
Participants
60%
Average Safety

Condition Evidence

Testicular cancer

7 trials · 50K participants

90% effectiveness · 60% safety
Retroperitoneal Lymph Node Dissection (RPLND) | DFDA